Search tips
ESCMID Global 2024
Courses & Events
Guidelines
From the archive: ECCMID and more before 2010
Search Results
Sort by:
Filter 0
Sort by
Filter
Sort by
Relevance
Date descending
Date ascending
28 April 2024 - P2731
Incidence of serotonin syndrome caused by tedizolid and concomitant serotonergic agents
Yingsi Fang, Lloyd Clarke, Brandon Smith, Sunish Shah
28 April 2024 - P1120
Safety and efficacy of tedizolid phosphate versus comparators in patients <12 years of age with acute bacterial skin and skin structure infections (ABSSSI<12 years of age with acute bacterial skin and skin structure infections (ABSSSI)
Rosie Mngqibisa, Oleksandr Fofanov, Carlos F. Grazioso, Ekaterina Kamenova, Mario Melgar Toledo, Yanko Parvanov, Melissa Boddicker, Natalya Broyde, Sandra Koseoglu, Lizbeth Romero, Mara Lee Stevens, Pamela Sears
18 April 2023 - P3279
Pharmacokinetic of tedizolid for disseminated nocardiosis in lung transplant patient
Davide Vita, Silvia Scabini, Amedeo De Nicolò, Simone Mornese Pinna, Mauro Mangiapia, Antonio D'Avolio, Francesco Giuseppe De Rosa, Silvia Corcione
18 April 2023 - P3277
The role of ceftobiprole therapeutic drug monitoring and tedizolid in the treatment of an addicted patient with multiple brain abscesses
Luca Montanari, Paola Della Siega, Francesco Tuniz, Jacopo Angelini, Miran Skrap, Simone Giuliano, Carlo Tascini
23 April 2022 - P0501
In vitro activity of tedizolid against Nocardia spp. isolated in Japan
Masahiro Toyokawa, Noboru Ohana, Daiki Tanno, Minako Imai, Mutsuko Honda, Yukiko Takano, Kazutaka Ohashi, Tomonari Yamashita, Kyoichi Saito, Hiroki Shimura
23 April 2022 - P0492
In vitro susceptibility testing of tedizolid against rapidly growing non-tuberculous mycobacteria
Marta Marchante, Raquel Ramiro, Laura Herrera-Leon
09 July 2021 - 1805
A PK/PD model-based analysis of tedizolid against E. faecalis in a hollow-fibre infection model
Khalid Iqbal, K. Iqbal, S.G. Wicha
09 July 2021 - 264
Five years of analysis of the in vitro activity of tedizolid against a worldwide collection of indicated species causing clinical infections: results from the Surveillance of Tedizolid Activity and Resistance (STAR) programme
Cecilia G. Carvalhaes, C.G. Carvalhaes, H.S. Sader, J.M. Streit, M. Castanheira, R.E. Mendes
09 July 2021 - 3523
Influence of tedizolid on circulating cytokines in the human lipopolysaccharide challenge
Anselm Jorda, A. Jorda (1), B. Wulkersdorfer (1), C. Schörgenhofer (1), P. Matzneller (1), V. Al Jalali (1), M. Bauer (1), E. Lackner (1), C. Dorn (2), B. Jilma (1), M. Zeitlinger (1)
09 July 2021 - 1178
Safety of tedizolid as suppressive antimicrobial therapy for patients with complex implant-associated bone and joint infection due to multidrug-resistant Gram-positive pathogens: results from the TediSAT cohort study
Tristan Ferry, T. Ferry (1), A. Conrad (1), E. Senneville (2), S. Roux (1), C. Dupieux-Chabert (1), A. Dinh (3), L. Sébastien (1), S. Goutelle (1), T. Briot (1), T.T. Pham (1), F. Valour (1)
15 April 2019 - P2122
Synergism between tedizolid and clarithromycin opens up possibilities in Mycobacterium abscessus  treatment
Mike Marvin Ruth, Mike Mientjes, Lian Pennings, Saskia Kuipers, Heiman Wertheim, Jakko van Ingen
15 April 2019 - P1883
Activity of tedizolid and comparators against Enterococcus spp. that include multidrug-resistant clinical isolates from European and US medical centres (2016-2018)
Rodrigo E. Mendes, Cecilia Carvalhaes, Helio S. Sader, Jennifer Streit, Robert Flamm
15 April 2019 - P1997
Tedizolid after daptomycin as step-down versus continuation of daptomycin against multidrug-resistant enterococci and Staphylococcus aureus using a rat endocarditis model
Cesar Arias, Kavindra Singh, Barbara Murray
13 April 2019 - P0550
Effect of tedizolid in combination with rifampicin or daptomycin on Staphylococcus aureus mature biofilm
Anna Gidari, Samuele Sabbatini, Claudia Monari, Stefano Perito, Daniela Francisci, Antonella Mencacci, Anna Vecchiarelli, Franco Baldelli
07 September 2018 - 111
Tedizolid In Vitro Activity against a Contemporary Challenge Collection of Multidrug-Resistant Enterococcal Clinical Isolates
24 April 2018 - P2227
Pharmacokinetics of tedizolid (TZD) in plasma and sputum in adults with cystic fibrosis
Hyun Ah Kim, A. Park, J. Wang, J. Jayne, D. D'Argenio, L. Fukushima, A. Rao, P. Beringer
24 April 2018 - P2071
Tedizolid (TZD) a promising therapeutic option for cystic fibrosis MRSA infections including strains with reduced activity
Adriana Rosato, M. Roch, A. Taglialegna, M. Varela, W. Rose, R. Ryan.M.Hergenrother, A. Rosato
24 April 2018 - P2228
Population pharmacokinetics, exposure-efficacy, and target attainment analyses of tedizolid in Japanese and Chinese subjects
Takahiko Tanigawa, T. Tanigawa, S. Willmann, D. Jaworowicz, J. Fiedler-Kelly, L. li, J. Passarell, Y. Tanimura, T. Tanaka
23 April 2018 - P1844
In vitro activity of tedizolid, dalbavancin and ceftobiprole against Clostridium difficile
Avi Peretz, d. binyamin, O. Nitzan, m. azrad, z. hamo, O. Koren, A. Peretz
23 April 2018 - P1807
Evaluation of tedizolid activity against Gram-positive clinical isolates causing pneumonia in Europe and surrounding areas (2014-2017)
Rodrigo E. Mendes, R. Mendes, H. Sader, D. Shortridge, M. Castanheira, R. Flamm
Loading ...
+ load more
FAQ
To access content in the Library you need to log in with your ESCMID member or user credentials. If you haven’t registered as an ESCMID member yet, then click here to do so – or use this link to register as a user.
The most recent event-related content is usually restricted to ESCMID members, while registered users get access one year after the event. However, there are events such as ESCMID Global where attendees get priority access, no matter if they are members or registered users. In these cases, we may offer non-attendees access after paying a fee.
You may search by event name, session title or number, topic title or number or author – or by any keyword. To get the most relevant results, enter the title or name in quotation marks, e.g. "Pre-ECCMID Day on Diagnostics" or "John Doe". If no quotation marks are used, then the exact result is shown first, followed by less exact results.
You may further narrow the number of search results for most terms by applying one or several filters, using the filter window on the start page. The Category and Media Type filters work for any content. In contrast, the Date from / to filter may not apply for Publications and Guidelines. In addition, the information text below a webcast or document offers the option of filtering search results by session title, author, event or category.
We defined four "hot topic" terms that you may search for by clicking the four tiles on the start page.
Linking two or more search terms by AND will show all results containing these search terms. For example, if you are looking for results that contain both the terms viral and hospital, then enter viral AND hospital.
Link two or more search terms by OR to get all results that contain at least one of these terms. For example, if you want to get results that contain either viral or infections or COVID, then enter viral OR infections OR COVID.
Place + in front of the term that you want to be included in your search result and place - in front of the term that you do not want to be included – without blanks in between in either case. For example, if you are aiming for search results that contain viral and infection but do not contain COVID, then enter +viral +infections -COVID.
A search term preceded by an exclamation point (no blanks in between) will lead to all content that does not contain the term, e.g. !COVID.
Deselect the ticked boxes in the filter dropdowns, click "Clear" on the calendars in the Date from / to filter – or refresh the website to remove all filters at once. Additionally, you may clear all applied filters by using the relevant buttons right above the search results.
No, as copyright protection limits the viewing of video presentations to web browsers, they cannot be downloaded.
No, due to our privacy policy we cannot disclose any contact details of persons involved.